Working… Menu

Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal Odor Not Caused by BV or Vaginitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00417365
Recruitment Status : Unknown
Verified August 2007 by Abbott Research Group.
Recruitment status was:  Recruiting
First Posted : January 1, 2007
Last Update Posted : August 15, 2007
Information provided by:
Abbott Research Group

Brief Summary:
Comparing the new Stainless Steel WaterWorks® douching device to a commercially available douching device using just water for safety and efficacy of odor abatement.

Condition or disease Intervention/treatment Phase
Vaginal Odor Device: WaterWorks Douching Device Not Applicable

Detailed Description:

Vaginal symptoms, including abnormal odor with or without complaints of discharge, are relatively common complaints. It is generally assumed that most women with these complaints have a vaginal infection, bacterial vaginosis, trichomoniasis, or vulvovaginal candidiasis. However, investigators suggest that there is a large population of women who complain of odor with or without complaints of discharge, and in whom no clear cause can be found. For these women, there are currently no treatment options.

Anecdotal evidence suggests that stainless steel used with just water has an effect in reducing odors and is so used to reduce odors on hands by chefs. The Water Works® Douching Device is a light-weight (1oz) stainless steel douching device that was developed to aid in the treatment of vaginal odor. Additional anecdotal evidence suggests that douching with the Water Works® Douching Device had little or no affect on the vaginal Eco-System (e.g. good bacteria, Lactobacilli).

This study (ARG105B) will compare the Water Works® Douching Device to a commercially available over the counter douching device for the ability to reduce or eliminate abnormal odor (with or without complaints of discharge) in women with this subjective complaint, but no objective findings of a vaginal infection. The study will also compare the Water Works® Douching Device to the commercial device with respect to the adverse effect of the vaginal Eco-System.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: "A Comparison Study of the WaterWorks® Douching Device vs. Commercial OTC Douching Device for the Reduction or Abatement of Perceived Vaginal Odor With or Without Complaints of Discharge in Women With no Infectious Causes of Vaginitis"
Study Start Date : August 2006
Estimated Study Completion Date : September 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Vaginitis

Primary Outcome Measures :
  1. The primary endpoint of the study is the reduction or abatement of the
  2. subject's perceived vaginal odor as determined at Visit 3.
  3. This improvement will be measured using a visual analog scale that
  4. asks subjects to rate their perception of vaginal odor on a scale that
  5. is anchored at two extremes, "no odor", and, "strong offensive odor".

Secondary Outcome Measures :
  1. Effects on the vaginal Eco-System will be assessed using the
  2. Lactobacilli score and the Nugent score. The safety profile of the douching
  3. device (Water Works® versus control) will be assessed through the collection
  4. of any reported adverse events. Any adverse event, will be reported in terms
  5. of severity, relationship to treatment, duration, and resolution.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Enrollment in the study will be open to those subjects who meet the following inclusion criteria:

  1. Non-pregnant females, 18 years and older
  2. Complaint of abnormal vaginal odor with or without complaints of discharge
  3. Subject with perceived, abnormal vaginal odor on the date she is evaluated
  4. Odor scale 4 cm or greater (using the subject's perception visual analog rating scale of 10 cm): 0 = no odor 10 = strong offensive odor
  5. Subject is not fulfilling Amsel's criteria for BV listed below (only meets 0 or 1 Amsel's criteria)
  6. Not treated for Bacterial Vaginosis, VVC, intra-vaginal or oral anti-fungal medications or antibiotics, within the last 14 days of enrollment
  7. Willing and able to comply with study requirements
  8. Has provided written informed consent

Exclusion Criteria:

Subjects will be excluded from the enrollment if they have any of the following:

  1. Odor scale less than 4 cm (on the Visual Analog rating scale of 10 cm)
  2. Subjects with presence of BV
  3. Subjects with other lower genital tract infections (e.g., symptomatic VVC, trichomoniasis, Chlamydia trachomatis, Neisseria gonorrhoeae or herpes simplex virus)
  4. Subjects with another vaginal or vulvar condition, which would confound the interpretation of clinical response
  5. Subjects who received antifungal or antimicrobial therapy (systemic or intravaginal) within the last 14 days
  6. Subjects who will be under treatment during the study period for cervical intra-epithelial neoplasia (CIN) or cervical carcinoma
  7. Positive pregnancy test
  8. Any abnormal anatomy or pathology of the subject's vagina
  9. Known HIV positive
  10. Pap smear >LSIL (untreated or not evaluated) [LSIL = Low-grade squamous intraepithelial lesion]
  11. Subject currently having a menstrual period (excluded until completion of period)
  12. Subjects with a body mass index (BMI) of 39 or greater
  13. Investigator believes that external factor(s) is producing odor

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00417365

Layout table for location information
United States, Florida
Segal Institute of Clinical Research Completed
Aventura, Florida, United States, 33161
Discovery Research, Inc. Withdrawn
Plantation, Florida, United States, 33324
United States, Georgia
Atlanta Women's Research Institute Active, not recruiting
Atlanta, Georgia, United States, 30342
United States, Michigan
Wayne State University, Harper Hospital Recruiting
Detroit, Michigan, United States, 48201
Contact: Debbie Leaman    313-577-5296   
Principal Investigator: Jack Sobel, M.D.         
United States, North Carolina
Salem Research Recruiting
Winston Salem, North Carolina, United States, 27103
Contact: Adrianna Fulda    336-760-3909   
Contact: Patricia Creed    (336) 760-3909   
Principal Investigator: Thomas Valaoras, M.D.         
United States, Oklahoma
University of Oklahoma Terminated
Tulsa, Oklahoma, United States, 74104
United States, Pennsylvania
Temple University Hospital Recruiting
Philadelphia, Pennsylvania, United States, 19140
Contact: Sarminia Hassan, M.D.    215-707-7278   
Principal Investigator: Ashwin Chatwni, M.D.         
Sponsors and Collaborators
Abbott Research Group
Layout table for investigator information
Principal Investigator: Ashwin Chatwani, M.D. Temple University
Principal Investigator: Jack Sobel, M.D. Wayne State University
Infectious Diseases in Obstetrics and Gynecology Volume 2006 (2006), Article ID 95618, 4 pages doi:10.1155/IDOG/2006/95618 /Published results are from ARG sponsored study ARG105.

Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information Identifier: NCT00417365    
Other Study ID Numbers: ARG105B
Pre-IDE I060071
First Posted: January 1, 2007    Key Record Dates
Last Update Posted: August 15, 2007
Last Verified: August 2007
Keywords provided by Abbott Research Group:
Additional relevant MeSH terms:
Layout table for MeSH terms
Vaginal Diseases